CompanyUNCYNasdaqMountain View, CA

Unicycive Therapeutics, Inc.

Unicycive Therapeutics develops treatments for kidney diseases.

SEC EDGAR ClinicalTrials.gov unicycive.com

8-KSep 29Latest SEC filing

Sep 29Latest story

September 2026

Unicycive resubmits NDA for oxylanthanum carbonate after June 2026 CRL

Sep 29Clinical readoutUnicycive Therapeutics, Inc.

August 2026

Unicycive says FDA has assigned facility inspection for OLC manufacturing vendor

Aug 12Quarterly updateUnicycive Therapeutics, Inc.